Peking Union Medical College Hospital: Anemia, Aplastic trials

The registry lists 20 Anemia, Aplastic studies with Peking Union Medical College Hospital as lead sponsor. 12 are open to participants now and 0 have results posted.

Phase 2 9Phase 3 3Phase 4 9No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Romiplostim N01 in Chemoradiotherapy-induced Aplastic AnemiaNot yet recruitingNCT07572084Phase 2
• CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAANot yet recruitingNCT07558434Phase 2
• Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAANot yet recruitingNCT07001397Phase 3
• Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin ARecruitingNCT06802055Phase 2
• A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAANot yet recruitingNCT06535685Phase 4
• Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAANot yet recruitingNCT06525948Phase 4
• Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm StudyNot yet recruitingNCT06516484Phase 4
• A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With LusutrombopagNot yet recruitingNCT06426043Phase 4
• Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction SystemRecruitingNCT06009965Phase 4
• Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAANot yet recruitingNCT06009497Phase 4
• A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAANot yet recruitingNCT06004791Phase 4
• Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the ElderlyRecruitingNCT06004752Phase 2
• Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AAWithdrawnNCT07532408Phase 2
• CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAAWithdrawnNCT07523009Phase 2
• Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAAWithdrawnNCT06424639Phase 4
• CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the ElderlyCompletedNCT05996393Phase 4
• Efficacy and Safety of Hetrombopag in Non-severe Aplastic AnemiaWithdrawnNCT05018936Phase 2/3
• Avatrombopag Usage in NSAAStatus unknownNCT04728789Phase 2/3
• Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia PatientsCompletedNCT04403321Phase 2
• Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron OverloadStatus unknownNCT02833493